Case Report
Published on 07 Jan 2022
Case Report: Significant Clinical Benefit From Pemetrexed-Based Therapy in ROS1- and ALK-rearranged Lung Cancer With Adenosquamous Histology
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.788245
- 4,339 views
- 5 citations


